One68 Global Capital’s Fresenius Medical Care FMS Stock Holding History

One68 Global Capital’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,000	Closed	-$203K	–	21
2019 Q1	$203K	Buy	+5,000	New	+$186K	0.61%	14

Other funds holding FMS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JFL

Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return

One68 Global Capital's FMS Position: Q2 2019 in Review

One68 Global Capital sold out of Fresenius Medical Care (FMS) in Q2 2019, closing a stake of 5,000 shares — an estimated $203K sold.

One68 Global Capital first reported a position in FMS in Q1 2019 and held it in 1 quarter. The position peaked at $203K in Q1 2019. 175 funds tracked by Wall St. Rank hold FMS as of Q2 2019.

One68 Global Capital reported no remaining Fresenius Medical Care position as of Q2 2019 after selling out during the quarter.
One68 Global Capital sold 5,000 Fresenius Medical Care shares in Q2 2019, an estimated $203K.
One68 Global Capital first reported a position in Fresenius Medical Care in Q1 2019 and held it in 1 quarter.
One68 Global Capital's Fresenius Medical Care position peaked at $203K in Q1 2019.
175 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2019.

Based on One68 Global Capital's 13F filing for Q2 2019, filed 7 Aug 2019.